OncoCyte Corp. | |
Stock Exchange | NYSE |
EPS |
$0.38 |
Market Cap |
$110.7 M |
Shares Outstanding |
51.97 M |
Public Float |
30.25 M |
OncoCyte Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
40.66 M |
Public Float |
11.95 M |
Address |
1010 Atlantic Avenue Alameda California 94501 United States |
Employees | - |
Website | http://www.oncocyte.com |
Updated | 07/08/2019 |
OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA. |